Brief: Abionyx Pharma Receives Compassionate Access Authorization By French Drug Safety Agency
Jan 3 (Reuters) - Abionyx Pharma SA ABNX.PA :
* ANNOUNCES THAT FRENCH DRUG SAFETY AGENCY HAS GRANTED A
COMPASSIONATE ACCESS AUTHORIZATION FOR BIO-HDL (CER-001) IN
COVID-19 DISEASE
Source text for Eikon: ID:nBw8TYwkna
Further company coverage: ABNX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls